This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
Contract awarded. Originally published 1 years ago.
No single supplier dominates the field.
In healthcare medical, BIAYSTOK ONCOLOGY CENTER NAMED AFTER MARIE CURIE IN BIAYSTOK has awarded 8 contracts to 8 suppliers.
+2 more suppliers
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the supply of equipment, software, and licenses as part of the digital transformation of the Białystok Oncology Center. The project is divided into several parts: Part 1 includes the delivery, migration, and implementation of the email management system for the cen
This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
This contract involves the design and execution of construction work to adapt the building formerly used by the CZMiS at 23 Ogrodowa Street for the needs of the Białystok Oncology Center (BCO). The project includes the construction of an underground connector for communication with the BCO hospital
This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.
Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.
Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.
UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.
